Philips | PHIA - Sales Revenues


Philips reported EUR3.91B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
ABB USD 8.73B 322M Mar/2026
Abbott USD 11.16B 300M Mar/2026
Aena EUR 1.48B 110M Mar/2026
Alcon AG USD 2.69B 10M Mar/2026
ASM International NV EUR 862.5M 164.2M Mar/2026
ASML Holding EUR 8.77B 951M Mar/2026
AstraZeneca USD 15.29B 213M Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Boston Scientific USD 5.2B 90M Mar/2026
Demant DKK 6.25B 800M Dec/2025
EDAP TMS EUR 15.42M 1.54M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.74B 140M Mar/2026
Fresenius Medical Care EUR 4.61B 460M Mar/2026
Geberit CHF 715.4M 67.1M Dec/2025
Getinge SEK 11.07B 3.2B Dec/2024
GN Store Nord DKK 3.85B 830M Mar/2026
GRIFOLS EUR 1.7B 280M Mar/2026
HeidelbergCement EUR 11.06B 5.38B Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
Koninklijke Philips EUR 4.51B 1.42B Mar/2026
Legrand EUR 2.54B 30M Mar/2026
Lonza CHF 3.58B 63M Jun/2025
Medtronic USD 9.8B 800M Mar/2026
Merck EUR 5.13B 120M Mar/2026
Philips EUR 3.91B 1.19B Mar/2026
Sanofi EUR 11.24B 60M Mar/2026
SAP EUR 9.56B 120M Mar/2026
Schneider Electric EUR 9.77B 0 Mar/2026
Smith & Nephew USD 3.18B 353M Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025